230
Views
45
CrossRef citations to date
0
Altmetric
Articles

Anti-apoA-1 IgG and oxidized LDL are raised in rheumatoid arthritis (RA): potential associations with cardiovascular disease and RA disease activity

, , , , &
Pages 447-453 | Accepted 02 Mar 2010, Published online: 06 Jul 2010

References

  • Frostegard J. Atherosclerosis in patients with autoimmune disorders. Arterioscler Thromb Vasc Biol 2005;25:1776–85.
  • Dinu AR, Merrill JT, Shen C, Antonov IV, Myones BL, Lahita RG. Frequency of antibodies to the cholesterol transport protein apolipoprotein A1 in patients with SLE. Lupus 1998;7: 355–60.
  • Abe H, Tsuboi N, Suzuki S, Sakuraba H, Takanashi H, Tahara K, Anti-apolipoprotein A-I autoantibody: characterization of monoclonal autoantibodies from patients with systemic lupus erythematosus. J Rheumatol 2001;28:990–5.
  • Delgado AJ, Ames PR, Donohue S, Stanyer L, Nourooz-Zadeh J, Ravirajan C, Antibodies to high-density lipoprotein and beta2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome. Arthritis Rheum 2002;46:2686–94.
  • Vuilleumier N, Reber G, James R, Burger D, de Moerloose P, Dayer JM, Presence of autoantibodies to apolipoprotein A-1 in patients with acute coronary syndrome further links autoimmunity to cardiovascular disease. J Autoimmun 2004; 23:353–60.
  • Vuilleumier N, Charbonney E, Fontao L, Alvarez M, Turck N, Sanchez JC, Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndrome. Clin Sci (Lond) 2008;115:25–33.
  • Berliner JA, Territo MC, Sevanian A, Ramin S, Kim JA, Bamshad B, Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest 1990;85:1260–6.
  • Frostegard J, Nilsson J, Haegerstrand A, Hamsten A, Wigzell H, Gidlund M. Oxidized low density lipoprotein induces differentiation and adhesion of human monocytes and the monocytic cell line U937. Proc Natl Acad Sci USA 1990;87:904–8.
  • Frostegard J, Wu R, Giscombe R, Holm G, Lefvert AK, Nilsson J. Induction of T-cell activation by oxidized low density lipoprotein. Arterioscler Thromb 1992;12:461–7.
  • Meisinger C, Baumert J, Khuseyinova N, Loewel H, Koenig W. Plasma oxidized low density lipoprotein, a strong predictor for acute heart disease events on apparently healthy, middle-aged men from the general population. Circulation 2005;112:651–7.
  • Shimada K, Mokuno H, Matsunaga E, Miyazaki T, Sumiyoshi K, Miyauchi K, Circulating oxidized low-density lipoprotein is an independent predictor for cardiac event in patients with coronary artery disease. Atherosclerosis 2004;174:343–7.
  • Yamashita H, Ehara S, Yoshiyama M, Naruko T, Haze K, Shirai N, Elevated plasma levels of oxidized low-density lipoprotein relate to the presence of angiographically detected complex and thrombotic coronary artery lesion morphology in patients with unstable angina. Circ J 2007;71:681–7.
  • Anselmi M, Garbin U, Agostoni P, Fusaro M, Pasini AF, Nava C, Plasma levels of oxidized-low-density lipoproteins are higher in patients with unstable angina and correlated with angiographic coronary complex plaques. Atherosclerosis 2006;185: 114–20.
  • Kim SH, Lee CK, Lee EY, Park SY, Cho YS, Yoo B, Serum oxidized low-density lipoproteins in rheumatoid arthritis. Rheumatol Int 2004;24:230–3.
  • Svenungsson E, Jensen-Urstad K, Heimbürger M, Silveira A, Hamsten A, de Faire U, Risk factors for cardiovascular disease in systemic lupus erythematosous. Circulation 2001;104:1887–93.
  • Matsuura E, Kobayashi K, Koike T, Shoenfeld Y, Khamashta MA, Hughes GR. Oxidized low-density lipoprotein as a risk factor of thrombosis in antiphospholipid syndrome. Lupus 2003; 12:550–4.
  • Zhao D, Ogawa H, Wang X, Cameron GS, Baty DE, Dlott JS, Oxidized low-density lipoprotein and autoimmune antibodies in patients with history of antiphospholipid syndrome with a history of thrombosis. Am J Clin Pathol 2001;116:760–7.
  • Arnett FC, Edworthy SM, Block DA, McShane DJ, Fries JF, Cooper NS, The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315–24.
  • Prevoo ML, van ‘t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44–8.
  • Ekdahl C, Eberhardt K, Andersson SI, Svensson B. Assessing disability in patients with rheumatoid arthritis. Use of a Swedish version of the Stanford Health Assessment Questionnaire. Scand J Rheumatol 1988;17:263–71.
  • Wendelhag I, Liang Q, Gustavsson T, Wikstrand J. A new automated computerized analyzing system simplifies readings and reduces the variability in ultrasound measurement of intima-media thickness. Stroke 1997;28:2195–200.
  • Jogestrand T, Nowak J, Sylven C. Improvement of common carotid intima-media complex measurements by calculating the cross-sectional area. J Vasc Invest 1995;4:193–5.
  • Nowak J, Nilsson T, Sylven C, Jogestrand T. Potential of carotid ultrasonography in the diagnosis of coronary artery disease: a comparison with exercise test and variance ECG. Stroke 1998;29:439–46.
  • Lemne C, Jogestrand T, de Faire U. Carotid intima-media thickness and plaque in borderline hypertension. Stroke 1995;26:34–9.
  • Del Rincon I, Williams K, Stern MP, Freeman GL, O’Leary DH, Escalante A. Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects. Arthritis Rheum 2003;48:1833–40.
  • Del Rincon I, O’Leary D H, Freeman GL, Escalante A. Acceleration of atherosclerosis during the course of rheumatoid arthritis. Atherosclerosis 2007;195:354–60.
  • Solomon DH, Karlson EW, Rimm EB, Cannuscio CC, Mandl LA, Manson JE, Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003;107:1303–7.
  • Wolfe F, Freundlich B, Straus WL. Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis. J Rheumatol 2003;30:36–40.
  • Jonsson SW, Backman C, Johnson O, Karp K, Lundstrom E, Sundqvist KG, Increased prevalence of atherosclerosis in patients with medium term rheumatoid arthritis. J Rheumatol 2001;28:2597–602.
  • Park YB, Ahn CW, Choi HK, Lee SH, In BH, Lee HC, Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound. Arthritis Rheum 2002;46:1714–19.
  • Kumeda Y, Inaba M, Goto H, Nagata M, Henmi Y, Furumitsu Y, Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis. Arthritis Rheum 2002;46:1489–97.
  • Elkayam O, Burke M, Vardinon N, Zakut V, Yitzhak RB, Paran D, Autoantibodies profile of rheumatoid arthritis patients during treatment with infliximab. Autoimmunity 2005;38:155–60.
  • Costenbader KH, Karslon EW. Cigarette smoking and autoimmune disease: what can we learn from epidemiology? Lupus 2006;15:737–45.
  • Harel-Meir M, Sherer Y, Shoenfeld Y. Tobacco smoking and autoimmune rheumatic disease. Nat Clin Pract Rheumatol 2007;3:707–15.
  • Edwards CJ, Syddall H, Goswami R, Goswami P, Dennison EM, Arden NK, Hertfordshire Cohort Study Group: the autoantibody rheumatoid factor may be an independent risk factor for ischaemic heart disease in men. Heart 2007;93:1263–7.
  • Winyard PG, Tatzber F, Esterbauer H, Kus ML, Blake DR, Morris CJ. Presence of foam cells containing oxidised low density lipoprotein in the synovial membrane from patients with rheumatoid arthritis. Ann Rheum Dis 1993;52:677–80.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.